These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37181075)

  • 1. Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series.
    Radenkovic S; Johnsen C; Schulze A; Lail G; Guilder L; Schwartz K; Schultz M; Mercimek-Andrews S; Boyer S; Morava E
    Ther Adv Rare Dis; 2023; 4():26330040221150269. PubMed ID: 37181075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation abnormalities and vascular complications are common in PGM1-CDG.
    Radenkovic S; Bleukx S; Engelhardt N; Eklund E; Mercimek-Andrews S; Edmondson AC; Morava E
    Mol Genet Metab; 2024 Jul; 142(4):108530. PubMed ID: 38968673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral D-galactose supplementation in PGM1-CDG.
    Wong SY; Gadomski T; van Scherpenzeel M; Honzik T; Hansikova H; Holmefjord KSB; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Hertecant J; Preston G; Jaeken J; Peeters N; Perez S; Nguyen DD; Crivelly K; Emmerzaal T; Gibson KM; Raymond K; Abu Bakar N; Foulquier F; Poschet G; Ackermann AM; He M; Lefeber DJ; Thiel C; Kozicz T; Morava E
    Genet Med; 2017 Nov; 19(11):1226-1235. PubMed ID: 28617415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
    Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
    Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new D-galactose treatment monitoring index for PGM1-CDG.
    Perales-Clemente E; Liedtke K; Studinski A; Radenkovic S; Gavrilov D; Oglesbee D; Matern D; Rinaldo P; Tortorelli S; Morava E; Raymond K
    J Inherit Metab Dis; 2021 Sep; 44(5):1263-1271. PubMed ID: 34043239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.
    Morava E
    Mol Genet Metab; 2014 Aug; 112(4):275-9. PubMed ID: 24997537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.
    Altassan R; Radenkovic S; Edmondson AC; Barone R; Brasil S; Cechova A; Coman D; Donoghue S; Falkenstein K; Ferreira V; Ferreira C; Fiumara A; Francisco R; Freeze H; Grunewald S; Honzik T; Jaeken J; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-da-Silva D; Pascoal C; Quelhas D; Raymond KM; Rymen D; Seroczynska M; Serrano M; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Voermans N; Witters P; Morava E
    J Inherit Metab Dis; 2021 Jan; 44(1):148-163. PubMed ID: 32681750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.
    Radenkovic S; Bird MJ; Emmerzaal TL; Wong SY; Felgueira C; Stiers KM; Sabbagh L; Himmelreich N; Poschet G; Windmolders P; Verheijen J; Witters P; Altassan R; Honzik T; Eminoglu TF; James PM; Edmondson AC; Hertecant J; Kozicz T; Thiel C; Vermeersch P; Cassiman D; Beamer L; Morava E; Ghesquière B
    Am J Hum Genet; 2019 May; 104(5):835-846. PubMed ID: 30982613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of galactose therapy in phosphoglucomutase 1 deficiency.
    Nolting K; Park JH; Tegtmeyer LC; Zühlsdorf A; Grüneberg M; Rust S; Reunert J; Du Chesne I; Debus V; Schulze-Bahr E; Baxter RC; Wada Y; Thiel C; van Schaftingen E; Fingerhut R; Marquardt T
    Mol Genet Metab Rep; 2017 Dec; 13():33-40. PubMed ID: 28794993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
    Fernlund E; Andersson O; Ellegård R; Årstrand HK; Green H; Olsson H; Gunnarsson C
    Forensic Sci Int Genet; 2019 Nov; 43():102111. PubMed ID: 31563034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous involvement is common in PGM1-CDG.
    Radenkovic S; Witters P; Morava E
    Mol Genet Metab; 2018 Nov; 125(3):200-204. PubMed ID: 30262252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose treatment improves immune deficiency in mannose phosphate isomerase-congenital disorder of glycosylation: case report and review of literature.
    De Graef D; Mousa J; Waberski MB; Morava E
    Ther Adv Rare Dis; 2022; 3():26330040221091283. PubMed ID: 37180423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1-CDG).
    Altassan R; Albert-Brotons DC; Alowain M; Al-Halees Z; Jaeken J; Morava E
    JIMD Rep; 2023 Mar; 64(2):123-128. PubMed ID: 36873091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.
    Abu Bakar N; Voermans NC; Marquardt T; Thiel C; Janssen MCH; Hansikova H; Crushell E; Sykut-Cegielska J; Bowling F; MØrkrid L; Vissing J; Morava E; van Scherpenzeel M; Lefeber DJ
    Transl Res; 2018 Sep; 199():62-76. PubMed ID: 30048639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG).
    Balakrishnan B; Altassan R; Budhraja R; Liou W; Lupo A; Bryant S; Mankouski A; Radenkovic S; Preston GJ; Pandey A; Boudina S; Kozicz T; Morava E; Lai K
    Transl Res; 2023 Jul; 257():1-14. PubMed ID: 36709920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. News on Clinical Details and Treatment in PGM1-CDG.
    Schrapers E; Tegtmeyer LC; Simic-Schleicher G; Debus V; Reunert J; Balbach S; Klingel K; Du Chesne I; Seelhöfer A; Fobker M; Marquardt T; Rust S
    JIMD Rep; 2016; 26():77-84. PubMed ID: 26303607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
    Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
    Mol Genet Metab; 2024 Jun; 142(4):108513. PubMed ID: 38917675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis.
    Conte F; Ashikov A; Mijdam R; van de Ven EGP; van Scherpenzeel M; Veizaj R; Mahalleh-Yousefi SP; Post MA; Huijben K; Panneman DM; Rodenburg RJT; Voermans NC; Garanto A; Koopman WJH; Wessels HJCT; Noga MJ; Lefeber DJ
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.
    Pérez B; Medrano C; Ecay MJ; Ruiz-Sala P; Martínez-Pardo M; Ugarte M; Pérez-Cerdá C
    J Inherit Metab Dis; 2013 May; 36(3):535-42. PubMed ID: 22976764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
    Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
    Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.